Cécile holds a Ph.D in fundamental Virology. Her research background focused on two human viruses: she first carried out research on Interferon antiviral effect against Hepatitis B virus, as a PhD fellow at Inserm U370/Institute Pasteur Paris, Pr. C. Bréchot’s Lab. As a postdoctoral research associate, she joined the Department of Immunology of Imperial College (London, UK), directed by Professor. C.R.M Bangham, to conduct a research project on Human T Lymphotropic Virus type 1 (HTLV-1) transmission. She then moved back in France to managed large biomedical research programmes, from basic research to clinical trials, working with internal scientists, medical doctors, technlogy transfert offices and international stakeholders. For 13 years, she get hands on experience in biomedical research programmes management and running collaborations in public-private partnerships, combining expertise in fundamental virology, immunology, vaccinology and clinical research. In 2015, she joined Institut Pasteur to coordinate actions of the Institut Pasteur Research & Innovation Carnot programme. In the frame of the Department for Scientific Programming and Incentive Actions, she also contributed to the scoping and development of a funding strategy to deliver the Institut Pasteur’scientific programme. Today Cécile is managing the Virology, Global Health and Computational Biology on all their scientific aspects.
2020Facing challenges with the novel coronavirus SARS-CoV-2 outbreak, Virologie (Montrouge) 2020 Mar;.
2018HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates, PLoS ONE 2018;13(11):e0207794.
2005Human MxA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice, J. Hepatol. 2005 Dec;43(6):965-72.
2001Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein, J. Virol. 2001 Mar;75(6):2684-91.